ERBB2 and breast carcinoma: Characterization of breast cancer subtypes using gene expression profiling and DNA copy number variation has led to depiction of HER2-positive and ‘triple negative’ breast cancers as part of a ‘high-grade pathway’ and certain low-grade ER/PR-positive breast cancers as part of the ‘low-grade pathway’ [67].